Quantbot Technologies LP Iovance Biotherapeutics, Inc. Transaction History

Quantbot Technologies LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$5.62 - $10.0 $127,394 - $226,680	-22,668 Reduced 58.27%	16,235 $103,000
Q3 2022 Nov 07, 2022	BUY	$9.53 - $13.11 $266,801 - $367,027	27,996 Added 256.68%	38,903 $372,000
Q2 2022 Aug 09, 2022	BUY	$6.38 - $18.33 $32,780 - $94,179	5,138 Added 89.06%	10,907 $120,000
Q1 2022 May 16, 2022	BUY	$12.38 - $19.1 $71,420 - $110,187	5,769 New	5,769 $96,000
Q4 2021 Feb 11, 2022	SELL	$16.55 - $27.63 $34,109 - $56,945	-2,061 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$20.35 - $26.63 $16,605 - $21,730	816 Added 65.54%	2,061 $50,000
Q2 2021 Aug 12, 2021	BUY	$16.33 - $33.07 $20,330 - $41,172	1,245 New	1,245 $32,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $1,404 - $2,576	-49 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$28.04 - $50.26 $1,373 - $2,462	49 New	49 $2,000
Q3 2020 Nov 16, 2020	SELL	$27.75 - $36.3 $2,053 - $2,686	-74 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $2,013 - $3,034	74 New	74 $2,000
Q4 2019 Feb 10, 2020	SELL	$17.95 - $29.41 $26,925 - $44,115	-1,500 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$17.99 - $26.0 $3,597 - $5,200	200 Added 15.38%	1,500 $27,000
Q2 2019 Aug 13, 2019	BUY	$9.78 - $24.52 $12,714 - $31,876	1,300 New	1,300 $31,000
Q2 2018 Aug 13, 2018	SELL	$12.45 - $16.95 $74,164 - $100,971	-5,957 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$8.1 - $19.5 $48,251 - $116,161	5,957 New	5,957 $100,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.35B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.